These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7122647)

  • 21. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD; Bepary S; Rouf AS
    Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New co-polymer zwitterionic matrices for sustained release of verapamil hydrochloride.
    Kostova B; Rachev D
    Acta Pharm; 2007 Dec; 57(4):429-39. PubMed ID: 18165187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
    Lu B; Wen R; Yang H; He Y
    Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
    Dvorácková K; Rabisková M; Masteiková R; Vocilková L
    Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid lipid extrusion of sustained release dosage forms.
    Reitz C; Kleinebudde P
    Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Statistical optimization of sustained-release preparations of sodium diclofenac in the form of inert matrices. I].
    Peña Romero A; Poncet M; Jinot JC; Chulia D
    Pharm Acta Helv; 1988; 63(11):309-14. PubMed ID: 3237724
    [No Abstract]   [Full Text] [Related]  

  • 31. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research on preparation of Shandantong sustained-release tablets].
    Yuan WP; Liu LN; Wang M
    Zhong Yao Cai; 2008 Oct; 31(10):1564-7. PubMed ID: 19230418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation studies on slow-release phosphate tablets for high-dosage administration in renal transplant patients [proceedings].
    Woodroffe R
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():68P. PubMed ID: 12346
    [No Abstract]   [Full Text] [Related]  

  • 35. [Statistical optimization for a sustained-release preparation with a diclofenac sodium base in inert matrices. II].
    Peña Romero A; Poncet M; Jinot JC; Chulia D
    Pharm Acta Helv; 1988; 63(12):333-42. PubMed ID: 3241814
    [No Abstract]   [Full Text] [Related]  

  • 36. A METHOD FOR RELEASE RATE DETERMINATION FROM SUSTAINED-RELEASE TABLETS.
    SJOEGREN J; ERVIK M
    Acta Pharm Suec; 1964 Dec; 1():219-26. PubMed ID: 14246018
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of precirol ATO 5 on the properties of tablets.
    Sekulović D
    Pharmazie; 1987 Jan; 42(1):61-2. PubMed ID: 3575405
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of technologic factors on the release of vincamine incorporated into hydrophilic matrices].
    Ventouras K; Boucherat J; Buri P
    Pharm Acta Helv; 1977; 52(5):119-23. PubMed ID: 928473
    [No Abstract]   [Full Text] [Related]  

  • 39. IN VITRO EVALUATION OF SUSTAINED-RELEASE TABLETS BY DUAL CHANNEL SCINTILLATION COUNTING.
    MONTGOMERY KO; FLEMMING CV; WEINSWIG MH; PARKE RF; SWARTZ HA
    J Pharm Sci; 1964 Mar; 53():340-1. PubMed ID: 14185030
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral sustained-release products: pro's and con's.
    Drug Ther Bull; 1984 Jul; 22(15):57-60. PubMed ID: 6468281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.